申请人:Takeda Pharmaceutical Company Limited
公开号:US07183276B2
公开(公告)日:2007-02-27
The present invention provides a compound represented by the formula (I)
wherein R1 is a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, an optionally substituted hydroxy group, an optionally substituted thiol group or an optionally substituted amino group,
A is an optionally substituted cyclic amino group or —NR2—W—D wherein R2 is a hydrogen atom or an alkyl group, W is a bond or a divalent acyclic hydrocarbon group, and D is an optionally substituted cyclic group, an optionally substituted amino group or an optionally substituted acyl group,
B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group,
X is an oxygen atom, a sulfur atom or an optionally substituted nitrogen atom, and
Y is a bond or a divalent acyclic hydrocarbon group, or a salt thereof, which is useful for the prophylaxis or treatment of diabetic neuropathy and the like.
本发明提供了一种化合物,其表示为式(I),其中R1为氢原子,卤素原子,可选取代的碳氢基团,可选取代的杂环基团,可选取代的羟基,可选取代的硫醇基或可选取代的氨基;A为可选取代的环状氨基基团或-NR2-W-D,其中R2为氢原子或烷基团,W为键或二价非环烷基团,D为可选取代的环状基团,可选取代的氨基或可选取代的酰基;B为可选取代的碳氢基团或可选取代的杂环基团;X为氧原子,硫原子或可选取代的氮原子;Y为键或二价非环烷基团。该化合物或其盐对于预防或治疗糖尿病性神经病变等疾病有用。